BioSpace News Archive

Business

BlueWind Medical Ltd. Appoints Charles F. Cargile as Chief Financial Officer

BlueWind Medical, Ltd., developer of the innovative RENOVA iStim™ implantable tibial neuromodulation device for treatment of Overactive Bladder, announced the addition of Charles F. Cargile to its leadership team as Chief Financial Officer.

April 12, 2022
·
3 min read
Drug Development

MediLink Therapeutics Receives FDA Clearance of IND Application for YL201 Antibody Drug Conjugate Product

MediLink Therapeutics announced that YL201, the first compound based on MediLink’s proprietary antibody-drug conjugate (ADC) technology platform, has been cleared on its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its Phase I first-in-human study.

April 12, 2022
·
1 min read
Business

ALX Oncology Appoints Itziar Canamasas, Ph.D., to its Board of Directors

ALX Oncology Holdings Inc. today announced the appointment of Itziar Canamasas, Ph.D., to its Board of Directors (the “Board”) effective April 11, 2022.

April 12, 2022
·
3 min read
BioMidwest

Bio-Techne and Cygnus Technologies, Part of Maravai Lifesciences, Introduce New Simple Plex HEK 293 HCP 3G Immunoassay

Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.

April 12, 2022
·
4 min read
Oncolytics Biotech® to Participate in a Fireside Chat at the Canaccord Genuity Horizons in Oncology Virtual Conference

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Thomas Heineman, M.D., Ph.D., the Company’s Chief Medical Officer, will be participating in a fireside chat at the Canaccord Genuity Horizons in Oncology Virtual Conference.

April 12, 2022
·
4 min read
Business

Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics

Persephone Biosciences Inc. and Ginkgo Bioworks today announced a collaboration to develop a novel therapeutics based on the bacterial genus Bacteroides.

April 12, 2022
·
5 min read
Drug Development

ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131 in Cholangiocarcinoma at AACR Annual Meeting 2022

ZielBio, Inc. will present new, preclinical data on the efficacy of its ZB131 drug in cholangiocarcinoma (CCA) models at the American Association for Cancer Research (AACR) Annual Meeting 2022.

April 12, 2022
·
3 min read
Drug Development

Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the initiation of a Phase 1/2 clinical study of DARE-HRT1.

April 12, 2022
·
11 min read
Recce Pharmaceuticals Announces Anti-Viral Patent Granted in Hong Kong for RECCE® Anti-Infectives

Recce Pharmaceuticals Limited is pleased to announce the Intellectual Property Department of the Hong Kong Special Administrative Region has granted patent family three, “Anti-Virus Agent and Method for Treatment of Viral Infection,” furthering marketing and manufacturing exclusivity to February 2037.

April 12, 2022
·
3 min read
Business

PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022

PerkinElmer, Inc. today announced that the Company will release its first quarter 2022 financial results after market close on Tuesday, May 3, 2022.

April 12, 2022
·
1 min read